NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 176 filers reported holding NEVRO CORP in Q2 2016. The put-call ratio across all filers is 0.80 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $938,000 | -53.0% | 15,000 | -40.0% | 0.02% | -52.1% |
Q2 2018 | $1,996,000 | -45.8% | 25,000 | -41.2% | 0.05% | -59.0% |
Q1 2018 | $3,683,000 | +11.1% | 42,500 | -11.5% | 0.12% | +37.6% |
Q4 2017 | $3,314,000 | -19.0% | 48,000 | +6.7% | 0.08% | -44.1% |
Q3 2017 | $4,090,000 | +44.6% | 45,000 | +18.4% | 0.15% | +27.7% |
Q2 2017 | $2,828,000 | +50.9% | 38,000 | +90.0% | 0.12% | +60.8% |
Q1 2017 | $1,874,000 | +134.5% | 20,000 | +81.8% | 0.07% | +89.7% |
Q4 2016 | $799,000 | +27.6% | 11,000 | +83.3% | 0.04% | 0.0% |
Q3 2016 | $626,000 | -41.8% | 6,000 | -58.8% | 0.04% | -53.0% |
Q2 2016 | $1,075,000 | -34.1% | 14,580 | -49.7% | 0.08% | +16.9% |
Q1 2016 | $1,632,000 | +157.0% | 29,000 | +208.5% | 0.07% | +65.1% |
Q4 2015 | $635,000 | – | 9,400 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 622,615 | $38,920,000 | 8.04% |
Tamarack Advisers, LP | 160,000 | $10,002,000 | 3.97% |
Birch Run Capital Advisors, LP | 187,425 | $11,716,000 | 3.72% |
Prosight Management, LP | 128,765 | $8,049,000 | 3.52% |
Ratan Capital Management LP | 38,653 | $2,416,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 579,463 | $36,222,000 | 1.39% |
Spark Investment Management LLC | 403,400 | $25,216,000 | 1.17% |
Sivik Global Healthcare LLC | 50,000 | $3,126,000 | 1.15% |
ArrowMark Colorado Holdings LLC | 1,882,009 | $117,644,000 | 1.11% |
PFM Health Sciences, LP | 721,229 | $45,084,000 | 1.00% |